EyePoint Pharmaceuticals Inc (NASDAQ:EYPT)
| 0.7598 Delayed Data As of Apr 03 |  -0.0343 / -4.32%Today’s Change | 0.70 Today|||52-Week Range 2.69 | -50.98% Year-to-Date |
Latest EYPT News | Press Releases
No recent news for EyePoint Pharmaceuticals Inc.
Today’s Trading
| Previous close | 0.79 |
| Today’s open | 0.75 |
| Day’s range | 0.75 - 0.84 |
| Volume | 28,638 |
| Average volume (3 months) | 722,617 |
| Market cap | $97.1M |
Data as of 4:00pm ET, 04/03/2020
Growth & Valuation
| Earnings growth (last year) | +48.14% |
| Earnings growth (this year) | +44.91% |
| Earnings growth (next 5 years) | +0.00% |
| Revenue growth (last year) | +247.76% |
| P/E ratio | NM |
| Price/Sales | 7.94 |
| Price/Book | 10.22 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SBBPStrongbridge Biophar... | -0.18 | -9.59% |
| AYTUAytu BioScience Inc | +0.05 | +3.50% |
| ERYPErytech Pharma SA | 0.00 | 0.00% |
| PTNPalatin Technologies... | +0.00 | +0.74% |
Data as of 4:04pm ET, 04/03/2020
Financials
| Next reporting date | May 6, 2020 |
| EPS forecast (this quarter) | -$0.10 |
| Annual revenue (last year) | $20.4M |
| Annual profit (last year) | -$56.8M |
| Net profit margin | -278.88% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Watertown, Massachusetts |
Forecasts
